AU1347701A - Oxetanone derivatives - Google Patents

Oxetanone derivatives

Info

Publication number
AU1347701A
AU1347701A AU13477/01A AU1347701A AU1347701A AU 1347701 A AU1347701 A AU 1347701A AU 13477/01 A AU13477/01 A AU 13477/01A AU 1347701 A AU1347701 A AU 1347701A AU 1347701 A AU1347701 A AU 1347701A
Authority
AU
Australia
Prior art keywords
oxetanone
derivatives
oxetanone derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU13477/01A
Other languages
English (en)
Inventor
John Jason Gentry Mullins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/431,551 external-priority patent/US6235305B1/en
Application filed by Individual filed Critical Individual
Publication of AU1347701A publication Critical patent/AU1347701A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/10—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having one or more double bonds between ring members or between ring members and non-ring members
    • C07D305/12—Beta-lactones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AU13477/01A 1999-10-29 2000-10-27 Oxetanone derivatives Abandoned AU1347701A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US09/431,551 US6235305B1 (en) 1999-10-29 1999-10-29 Essentially nonabsorbable lipase inhibitor derivatives, pharmaceutical compositions and methods of use therefor
US09431551 1999-10-29
US16596099P 1999-11-17 1999-11-17
US06165960 1999-11-17
US61832800A 2000-07-18 2000-07-18
US09618328 2000-07-18
PCT/US2000/029592 WO2001032670A1 (fr) 1999-10-29 2000-10-27 Dérivés d'oxétanone

Publications (1)

Publication Number Publication Date
AU1347701A true AU1347701A (en) 2001-05-14

Family

ID=27389199

Family Applications (2)

Application Number Title Priority Date Filing Date
AU13477/01A Abandoned AU1347701A (en) 1999-10-29 2000-10-27 Oxetanone derivatives
AU12381/01A Abandoned AU1238101A (en) 1999-10-29 2000-10-27 Oxetanone derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU12381/01A Abandoned AU1238101A (en) 1999-10-29 2000-10-27 Oxetanone derivatives

Country Status (8)

Country Link
EP (1) EP1144377A4 (fr)
JP (1) JP2003524685A (fr)
CN (1) CN1342169A (fr)
AU (2) AU1347701A (fr)
CA (1) CA2358921A1 (fr)
IL (1) IL144045A0 (fr)
MX (1) MXPA01006755A (fr)
WO (2) WO2001032616A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030027786A1 (en) 2001-06-06 2003-02-06 Karsten Maeder Lipase inhibiting composition
US6730319B2 (en) 2001-06-06 2004-05-04 Hoffmann-La Roche Inc. Pharmaceutical compositions having depressed melting points
DE102004009076A1 (de) * 2004-02-23 2005-10-27 Solvay Pharmaceuticals Gmbh Alkylcarbamat-substituierte β-Lactone, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US7074822B2 (en) 2004-02-23 2006-07-11 Solvay Pharmaceuticals Gmbh Alkyl carbamate-substituted β-lactones, process for their preparation, and pharmaceutical compositions containing them

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS608117B2 (ja) * 1977-02-08 1985-02-28 財団法人微生物化学研究会 新生理活性物質エステラスチンおよびその製造法
GB2023604B (en) * 1978-05-25 1982-07-28 Microbial Chem Res Found Physiologically active derivatives of esterastin and production thereof
US5246960A (en) * 1984-12-21 1993-09-21 Hoffmann-La Roche Inc. Oxetanones
CA1328881C (fr) * 1984-12-21 1994-04-26 Pierre Barbier Procede pour la fabrication d'oxetanones
CA1270837A (fr) * 1984-12-21 1990-06-26 Hoffmann-La Roche Limited Oxetanones
IL97148A (en) * 1990-02-26 1996-11-14 Hoffmann La Roche Oxetanones a process for their manufacture and pharmaceutical compositions containing them
CA2128044C (fr) * 1993-08-05 2007-02-20 Klaus-Dieter Bremer Compositions pharmaceutiques comportant un glucosidase et/ou un inhibiteur d'amylase, et un inhibiteur des lipases

Also Published As

Publication number Publication date
JP2003524685A (ja) 2003-08-19
CN1342169A (zh) 2002-03-27
AU1238101A (en) 2001-05-14
CA2358921A1 (fr) 2001-05-10
MXPA01006755A (es) 2003-05-15
WO2001032670A1 (fr) 2001-05-10
WO2001032616A3 (fr) 2002-01-10
EP1144377A1 (fr) 2001-10-17
EP1144377A4 (fr) 2002-05-02
WO2001032616A2 (fr) 2001-05-10
IL144045A0 (en) 2002-04-21

Similar Documents

Publication Publication Date Title
AU6314900A (en) Biarylurea derivatives
AU6714700A (en) Cyclopropylindole derivatives
AU2001280099A1 (en) 4-acylaminopyrazole derivatives
AU2001230584A1 (en) 1h-imidazopyridine derivatives
AU2001230537A1 (en) Pyridoxazine derivatives
AU2001281802A1 (en) 6-phenylpyrrolopyrimidinedione derivatives
AU2001278790A1 (en) 1h-imidazopyridine derivatives
AU5429000A (en) Novel bicyclonucleoside derivatives
AU2002213978A1 (en) Substituted C-cyclohexylmethylamine derivatives
AU7319800A (en) 4-oxybenzopyran derivative
AU7952800A (en) 2-alkoxybenzene derivatives
AU3670000A (en) Novel thiazolobenzimidazole derivatives
AU2001254661A1 (en) Aminosulfonylbiphenyl derivatives
AU7453900A (en) 4-oxybenzopyran derivative
AU6262300A (en) Indolinylamide derivatives
AU2001289937A1 (en) Substituted 1-aminobutan-3-ol derivatives
AU2001230565A1 (en) Perfluoroisopropylbenzene derivatives
AU2830800A (en) Chroman derivatives
AU2001242772A1 (en) 3-substituted-4-pyrimidone derivatives
AU6050500A (en) Benzothiophene derivatives
AU1347701A (en) Oxetanone derivatives
AU1558300A (en) 1-cycloalkylpyrazoyl-benzoyl derivatives
AU1347601A (en) Oxetanone derivatives
AU2002212263A1 (en) Substituted 5-amino-1-pentene-3-ol derivatives
AU2002221632A1 (en) 5-amino-1-pentene-3-ol substituted derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase